These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19200174)

  • 1. Difference in drug resistance patterns between minor HIV-1 populations in cerebrospinal fluid and plasma.
    Bergroth T; Ekici H; Gisslén M; Hagberg L; Sönnerborg A
    HIV Med; 2009 Feb; 10(2):111-5. PubMed ID: 19200174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of M184I/V in minor HIV-1 populations of patients with lamivudine and/or didanosine treatment failure.
    Svedhem V; Bergroth T; Lidman K; Sönnerborg A
    HIV Med; 2007 Nov; 8(8):504-10. PubMed ID: 17944683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of drug-resistant HIV-1 during the early phase of viral decay is uncommon in treatment-naïve patients initiated on a three- or four-drug antiretroviral regimen including lamivudine.
    Bergroth T; Ekici H; Gisslén M; Loes SK; Goh LE; Freedman A; Lampe F; Johnson MA; Sönnerborg A
    J Med Virol; 2009 Jan; 81(1):1-8. PubMed ID: 19031460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children].
    Sáez-Llorens X; Castrejón de Wong MC; Castaño E; de Suman O; Báez de Ulloa C; Redondo W; Espino M
    Rev Med Panama; 2001; 26():13-8. PubMed ID: 16161718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination of lamivudine resistant minor HIV-1 variants by selective real-time PCR.
    Bergroth T; Sönnerborg A; Yun Z
    J Virol Methods; 2005 Jul; 127(1):100-7. PubMed ID: 15893572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.
    Spudich S; Lollo N; Liegler T; Deeks SG; Price RW
    J Infect Dis; 2006 Dec; 194(12):1686-96. PubMed ID: 17109340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
    Peuchant O; Thiébaut R; Capdepont S; Lavignolle-Aurillac V; Neau D; Morlat P; Dabis F; Fleury H; Masquelier B;
    AIDS; 2008 Jul; 22(12):1417-23. PubMed ID: 18614864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
    Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
    J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 drug resistance surveillance using dried whole blood spots.
    Bertagnolio S; Soto-Ramirez L; Pilon R; Rodriguez R; Viveros M; Fuentes L; Harrigan PR; Mo T; Sutherland D; Sandstrom P
    Antivir Ther; 2007; 12(1):107-13. PubMed ID: 17503754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma.
    Antinori A; Perno CF; Giancola ML; Forbici F; Ippolito G; Hoetelmans RM; Piscitelli SC
    Clin Infect Dis; 2005 Dec; 41(12):1787-93. PubMed ID: 16288405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV type-1 transmission dynamics in recent seroconverters: relationship with transmission of drug resistance and viral diversity.
    Recordon-Pinson P; Anies G; Bruyand M; Neau D; Morlat P; Pellegrin JL; Groppi A; Thiébaut R; Dabis F; Fleury H; Masquelier B;
    Antivir Ther; 2009; 14(4):551-6. PubMed ID: 19578240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
    Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of minor variants of HIV strains at reverse transcriptase position 103 in therapy-naïve patients and their impact on the virological failure.
    Balduin M; Oette M; Däumer MP; Hoffmann D; Pfister HJ; Kaiser R
    J Clin Virol; 2009 May; 45(1):34-8. PubMed ID: 19375978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.
    Cunningham PH; Smith DG; Satchell C; Cooper DA; Brew B
    AIDS; 2000 Sep; 14(13):1949-54. PubMed ID: 10997399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretation of high levels of HIV-1 RNA in the cerebrospinal fluid (CSF) using amplicor HIV-1 monitor test.
    Honderlick P; Zucman D; Couderc LJ
    Pathol Biol (Paris); 1999 May; 47(5):560-2. PubMed ID: 10418040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people.
    Vitiello B; Goodkin K; Ashtana D; Shapshak P; Atkinson JH; Heseltine PN; Eaton E; Heaton R; Lyman WD
    AIDS; 2007 Jul; 21(11):1415-22. PubMed ID: 17589187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma.
    Monteiro de Almeida S; Letendre S; Zimmerman J; Lazzaretto D; McCutchan A; Ellis R
    J Neuroimmunol; 2005 Dec; 169(1-2):144-52. PubMed ID: 16182380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
    Buckton AJ; Bissett SL; Myers RE; Beddows S; Edwards S; Cane PA; Pillay D
    J Antimicrob Chemother; 2008 Dec; 62(6):1191-8. PubMed ID: 18927229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of HIV-1 RNA levels in plasma and CSF of asymptomatic HIV-1 infected patients from South India using a TaqMan real time PCR assay.
    Kamat A; Ravi V; Desai A; Satishchandra P; Satish KS; Borodowsky I; Subbakrishna DK; Kumar M
    J Clin Virol; 2007 May; 39(1):9-15. PubMed ID: 17368087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.